摘要:
A wireless communication device is provided to carry out correlation peak detection processing properly and efficiently in intermittent receiving unit. If a correlation peak is not detected in a first period in which a correlation peak detecting unit detects the correlation peak at a default frequency and a first frequency in a detecting period of a coarse frequency deviation detecting unit in the first period, a control unit makes the correlation peak detecting unit carry out the peak detection at the first frequency in a second period. If the correlation peak is detected in the correlation peak detecting unit and a second frequency is detected in a detecting period of a fine frequency deviation detecting unit in the first period, the control unit makes the correlation peak detecting unit carry out the peak detection at the first and second frequencies in a third period.
摘要:
A signal processing unit and a wireless communication device are provided for making it possible to detect a frequency by means of a small scale operation circuit in a short time. The signal processing unit and the wireless communication device are comprised of a carrier data generating unit; a carrier demodulation unit; a matched filter unit that divides carrier demodulated data into a plurality of portions, carries out despread processing and accumulating operation processing as partial correlation processing, further carries out full addition processing for the partial correlation processing result, and outputs correlation detected data; a correlation peak detecting unit that detects a correlation peak from the correlation detected data and outputs correlation peak position information; a coarse frequency deviation detecting unit that outputs a frequency deviation amount with respect to the carrier demodulated data to the carrier data generating unit; and a fine frequency deviation detecting unit that outputs a fine frequency deviation amount from the correlation detected data and the correlation peak position information to the carrier data generating unit.
摘要:
An N-phenylarylsulfonylamide compound of formula (I) (R1 is COOH etc.; R2 is hydrogen, methyl, etc.; R3 and R4 are a combination of methyl and methyl, etc.; R5 is isopropyl etc.; Ar is thiazolyl, pyridyl, 5-methyl-2-furyl each optionally substituted with methyl; n is zero or 1), a synthetic intermediate for the compound and a process for its preparation. The compound of formula (I) binds to a prostaglandin E2 receptor, especially an EP1 subtype receptor, and antagonizes it. It is less affected by protein binding, so it has a satisfactory in vivo activity. Therefore, it is considered to be useful as an analgesic, an antipyretic agent, an agent for the treatment of pollakiuria (frequent urination) and/or lower urinary tract disease syndrome or an antineoplastic agent.
摘要翻译:式(I)的N-苯基芳基磺酰胺化合物(R 1)是COOH等; R 2是氢,甲基等; R 3 O >和R 4是甲基和甲基等的组合; R 5是异丙基等; Ar是噻唑基,吡啶基,5-甲基-2-呋喃基 任选被甲基取代; n为0或1),化合物的合成中间体及其制备方法。 式(I)化合物与前列腺素E 2受体结合,特别是EP 1亚型受体,并拮抗它。 蛋白质结合的影响较小,因此具有令人满意的体内活性。 因此,认为可用作止痛剂,解热剂,治疗尿频(尿频)和/或下尿路疾病综合征或抗肿瘤药物的药剂。
摘要:
An N-phenylarylsulfonylamide compound of formula (I) (R1 is COOH etc.; R2 is hydrogen, methyl, etc.; R3 and R4 are a combination of methyl and methyl, etc.; R5 is isopropyl etc.; Ar is thiazolyl, pyridyl, 5-methyl-2-furyl each optionally substituted with methyl; n is zero or 1), a synthetic intermediate for the compound and a process for its preparation. The compound of formula (I) binds to a prostaglandin E2 receptor, especially an EP1 subtype receptor, and antagonizes it. It is less affected by protein binding, so it has a satisfactory in vivo activity. Therefore, it is considered to be useful as an analgesic, an antipyretic agent, an agent for the treatment of pollakiuria (frequent urination) and/or lower urinary tract disease syndrome or an antineoplastic agent.
摘要翻译:式(I)的N-苯基芳基磺酰胺化合物(R 1)是COOH等; R 2是氢,甲基等; R 3 O >和R 4是甲基和甲基等的组合; R 5是异丙基等; Ar是噻唑基,吡啶基,5-甲基-2-呋喃基 任选被甲基取代; n为0或1),化合物的合成中间体及其制备方法。 式(I)化合物与前列腺素E 2受体结合,特别是EP 1亚型受体,并拮抗它。 蛋白质结合的影响较小,因此具有令人满意的体内活性。 因此,认为可用作止痛剂,解热剂,治疗尿频(尿频)和/或下尿路疾病综合征或抗肿瘤药物的药剂。
摘要:
An 8-azaprostaglandin represented by formula (I) (wherein all symbols have the same meanings as described in the specification), a pharmaceutically acceptable salt thereof or a cyclodextrin clathrate thereof. Since the compound represented by formula (I) binds to EP2 subtype among PGE receptor strongly, it is useful for preventive and/or treatment for immune diseases, allergic diseases, neuronal cell death, dysmenorrhea, premature birth, abortion, baldness, retinal neuropathy such as glaucoma, erectile dysfunction, arthritis, pulmonary injury, pulmonary fibrosis, pulmonary emphysema, bronchitis, chronic obstructive pulmonary disease, hepatic injury, acute hepatitis, liver cirrhosis, shock, nephritis, renal failure, circulatory diseases, systemic inflammatory response syndrome, sepsis, hemophagocytosis syndrome, macrophage activation syndrome, still disease, Kawasaki Disease, burn, systemic granuloma, ulcerative colitis, Crohn disease, hypercytokinemia at dialysis, multiple organ failure, or bone diseases etc.
摘要:
A headstock 10 having a chuck 12 and a tailstock 20 having a shaft 21 are mounted on a bed 1 and can move with respect to each other in the direction of the Z-axis, A carriage 50 is slidably mounted on the bad 1 and can move in the Z-axis direction with respect to the rotational axis of a spindle 11. A turning device (lathe tool) 30 is provided to perform a turning operation on a workpiece and a gear cutting device 40 is provided to perform a gear cutting on the workpiece. The turning device 30 and the gear cutting device are preferably slidably mounted on the carriage 50 in a side-by-side relationship. The turning device 30 and the gear cutting device 40 may have respective traverse slide bases 31 and 41. The traverse slide bases 31 and 41 are mounted on the carriage 50 and can move independently in the direction of the X-axis perpendicular to the axis of the spindle 11, i.e. in a traverse sliding direction.
摘要:
Synthetic methods for lactone-containing compounds such as the discodermolides are provided, as are compounds which mimic the chemical and/or biological activity thereof, and methods and intermediates useful in their preparation.
摘要:
A novel metal-encapsulated fullerene compound wherein a side chain is introduced in a metal-encapsulated fullerene is provided.A metal-encapsulated fullerene compound represented by the following structural formula (1) is synthesized by causing a disilirane derivative or digermirane derivative having the following structural formula (2) to react with a metal-encapsulation fullerene so as to add functional groups to the fullerene. ##STR1## Herein, M is an encapsulated metal atom, m is an integer from 1 to 3, n is an even number from 28 to 200, and R is a t-butyl group or an aromatic group having alkyl groups in the 2,6-positions, such as mesityl, 2,6-diethylphenyl or 2,6-dimethylphenyl groups.
摘要:
An input video signal is applied to a transmission line first through a time direction emphasizer for emphasizing the levels of time direction high frequency components of the video signal, relative to the levels of low frequency components thereof; secondary through a vertical direction emphasizer; and thirdly through a horizontal direction emphasizer. Further, the received video signal is outputted as an output video signal from the transmission line first through a horizontal direction deemphasizer for deemphasizing the levels of horizontal direction high frequency components of the video signal, relative to the levels of low frequency components thereof; secondary through a vertical direction deemphasizer; and thirdly through a time direction deemphasizer. The emphasis and deemphasis method enables the dynamic range of the transmission line to be utilized effectively, while preventing erroneous operation on the reception side.
摘要:
A process for producing recombinant human serum albumin (HSA) which comprises culturing an HSA producing host prepared by gene manipulation techniques at a temperature of from 21.degree. to 29.degree. C. Culturing the HSA producing host under such a specified temperature condition makes it possible to increase productivity of HSA production, improve the growth yield of an HSA producing host, and reduce the degree of coloring in the HSA preparation.